Nacuity Pharmaceuticals
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
306 W 7th St Ste 310, Fort Worth, Texas,...Phone Number
(817) 336-3000Website
www.nacuity.comRevenue
<$5 MillionIndustry
About Nacuity Pharmaceuticals
Nacuity Pharmaceuticals is a leader in developing innovative treatments aimed at stopping oxidative tissue damage, which is a significant factor in blinding eye diseases and various chronic conditions. The company focuses on targeted therapies and has several differentiated clinical programs, including those for retinitis pigmentosa, cataract, and cystinosis. Their intended clients include patients suffering from these eye diseases and healthcare providers seeking advanced treatment options. Nacuity's commitment to addressing oxidative stress positions it as a key player in the pharmaceutical industry.Explore more
Nacuity Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Nacuity Pharmaceuticals
Compare insights from companies similar to Nacuity Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nacuity Pharmaceuticals Tech Stack
A closer look at the technologies used by Nacuity Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nacuity Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Nacuity Pharmaceuticals is a leader in developing innovative treatments aimed at stopping oxidative tissue damage, which is a significant factor in blinding eye diseases and various chronic conditions. The company focuses on targeted therapies and has several differentiated clinical programs, including those for retinitis pigmentosa, cataract, and... Read More
